Sharon Pritchard

Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell Lung Cancer

Craig H. Reynolds, David Barrera, Robert M. Jotte et al. · Journal of Thoracic Oncology · 2009 · 58 citations · Full text

Medicine, Oncology, Pharmacology +16

Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer

Mark A. Socinski, Robert N. Raju, Thomas E. Stinchcombe et al. · Journal of Thoracic Oncology · 2010 · 34 citations · Full text

Medicine, Oncology, Pharmacology +13

A Phase III Randomized Trial of Gemcitabine–Oxaliplatin versus Carboplatin–Paclitaxel as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer

Charles H. Weissman, Craig H. Reynolds, Marcus A. Neubauer et al. · Journal of Thoracic Oncology · 2011 · 23 citations · Full text

Medicine, Oncology, Pharmacology +14

Comparison of the prognostic value of the 6th and 7th editions of the Union for International Cancer Control TNM staging system in patients with lower esophageal cancer undergoing neoadjuvant chemotherapy followed by surgery

Sharmila Mehta, Pinto Llerena Jose, A. H. MIRZA et al. · Diseases of the Esophagus · 2012 · 17 citations · Full text

Medicine, Oncology, Surgery +17